KKR & Co. (KKR) Acquires Bushu Pharmaceuticals
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/29/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
KKR to Acquire Bushu Pharmaceuticals
December 20, 2022 2:19 AM ESTTOKYO & SAITAMA, Japan--(BUSINESS WIRE)-- KKR, a leading global investment firm, and Bushu Pharmaceuticals Ltd. (Bushu Pharma or the Company) today announced the signing of definitive agreements under which KKR will acquire all shares in Bushu Pharma from BPEA EQT. Following the transactions completion, KKR aims to accelerate Bushu Pharmas growth and further position the Company as a leading contract development and manufacturing organization (CDMO) for the pharmaceuticals market in Japan and worldwide.
This press release features multimedia. View the full release here:... More
